Seligman Healthcare Spectrum Fund LLC
Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.
Raised
$10M
Investors
2
Min Invest
None stated
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
What this filing shows
·Every sentence is a value as filed on SEC Form D
Seligman Healthcare Spectrum Fund LLC is a Delaware limited liability company organized in 2024 that first filed a Form D on March 26, 2024 and most recently amended it on October 23, 2026, describing itself as a hedge fund. The offering claims Section 3(c)(7), Rule 506(b), Section 3(c) and covers equity. Seligman Healthcare Spectrum Fund LLC reported $10,010,000 sold from 2 investors in an offering of indefinite size as of the Form D filed October 23, 2026. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(7), each investor must be a qualified purchaser, generally an individual with at least $5 million in investments. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated. The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is 290 Congress Street, Boston, MA 02210.
Critical Disclosures
What the filings and the regulators have said about this entity that a reader should know first. Each line links to its source. The history, the same event across other issuers, and alerts are in the terminal.
Offering stalled · Form D · last filing October 23, 2026
Latest annual amendment reported no change in amount sold or investors
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
3
latest Oct 23, 2026
Critical / warning
0 / 0
2 watch · 1 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
1
stalled
Latest event Stalled · Oct 23, 2026
SEC.govFund family Part of the Seligman Healthcare Spectrum Fund family: 2 vehicles across 0 generations; Same adviser as Columbia Credit Income Opportunities Fund · adviser of record Columbia Management Investment Advisers, LLC · full family and the filing behind each link in the terminal
Investor
- The full fund family and 1 related vehicle (parallel, feeder, successor, sibling series) with the filing that shows each link
- 3 filing events with values and deltas, latest 2026-10-23, and alerts on the next one
- 1 offering timeline: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Adviser of Record (Form ADV)
CRD 108257 · SEC-registered adviser · lists this fund on Schedule D 7.B.(1) as a hedge fund
Auditor named on Form ADV: PricewaterhouseCoopers LLP · PCAOB-registered per the adviser
From the adviser's Form ADV as loaded from the SEC bulk data, joined on this issuer's Form D file number. Fund-level figures and the adviser's full fund roster are in the terminal.
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Item 3 changed on the Form D filed 2026-10-23: 1 related person added and 1 removed against the filing of 2025-10-03; 8 now listed. The names are in the Terminal feed.
CTPFMM, LLC
Executive Officer, Promoter · Wilmington, DE
The Managing Member of the Issuer.
Columbia Management Investment Advisers, LLC
Director, Promoter · Boston, MA
The Investment Manager of the Issuer.
Gurnek Teja
Director · Boston, MA
Mr. Teja is a director of the Managing Member of the Issuer and is an employee of the Investment Manager of the Issuer.
Grant Jackson
Director · Boston, MA
Mr. Jackson is a director of the Managing Member of the Issuer.
David Litton
Director · Boston, MA
Mr. Litton is a director of the Managing Member of the Issuer.
John Banks
Director · Boston, MA
Mr. Banks is a director of the Managing Member of the Issuer.
Matthew Rich
Executive Officer · Boston, MA
Mr. Rich is an authorized signatory of the Issuer.
Amy L. Hackbarth
Executive Officer · Minneapolis, MN
Ms. Hackbarth is an authorized signatory of the Issuer.
Questions About Seligman Healthcare Spectrum Fund LLC
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is Seligman Healthcare Spectrum Fund LLC?
Seligman Healthcare Spectrum Fund LLC is a Delaware limited liability company organized in 2024 that filed a Form D with the SEC on October 23, 2026 as a hedge fund. The filing claims Section 3(c)(7), Rule 506(b), Section 3(c) for an offering of equity.
Is Seligman Healthcare Spectrum Fund LLC legit?
AltStreet does not rate legitimacy; it reports the public record. Seligman Healthcare Spectrum Fund LLC filed a Form D with the SEC on October 23, 2026 claiming Section 3(c)(7), Rule 506(b), Section 3(c). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $10,010,000 sold to 2 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is Seligman Healthcare Spectrum Fund LLC registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Seligman Healthcare Spectrum Fund LLC claimed Section 3(c)(7), Rule 506(b), Section 3(c) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has Seligman Healthcare Spectrum Fund LLC raised?
Seligman Healthcare Spectrum Fund LLC reported $10,010,000 sold from 2 investors in an offering of indefinite size as of the Form D filed October 23, 2026.
Who can invest in Seligman Healthcare Spectrum Fund LLC?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(7), each investor must be a qualified purchaser, generally an individual with at least $5 million in investments. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated.
What is the minimum investment in Seligman Healthcare Spectrum Fund LLC?
The Form D lists the minimum investment as $0, which means the issuer did not state a minimum on the form. The offering documents, not the Form D, set the actual subscription terms.
Who is selling Seligman Healthcare Spectrum Fund LLC and how are they paid?
The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.
Who is behind Seligman Healthcare Spectrum Fund LLC?
The Form D lists 8 related persons: CTPFMM, LLC, executive officer, promoter (The Managing Member of the Issuer); Columbia Management Investment Advisers, LLC, director, promoter (The Investment Manager of the Issuer); Gurnek Teja, director (Mr. Teja is a director of the Managing Member of the Issuer and is an employee of the Investment Manager of the Issuer); Grant Jackson, director (Mr. Jackson is a director of the Managing Member of the Issuer); David Litton, director (Mr. Litton is a director of the Managing Member of the Issuer); John Banks, director (Mr. Banks is a director of the Managing Member of the Issuer); Matthew Rich, executive officer (Mr. Rich is an authorized signatory of the Issuer); Amy L. Hackbarth, executive officer (Ms. Hackbarth is an authorized signatory of the Issuer). Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is Seligman Healthcare Spectrum Fund LLC located?
The issuer's address on its SEC filings is 290 Congress Street, Boston, MA 02210. Its phone number of record is 612-678-0121. It is organized under the laws of Delaware.
How long is the Seligman Healthcare Spectrum Fund LLC offering open?
The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 2 amendments are on record for this CIK.
How large is Seligman Healthcare Spectrum Fund LLC?
The issuer declined to disclose its net asset value range on the Form D, which the form permits.

Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
